BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Bad Night: Purdue Pharma L.P. Axes 90 Reps of Transcept Pharmaceuticals, Inc. (TSPT) Sleep Drug


5/14/2013 8:39:47 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Purdue Pharmaceuticals LP will shelve 90 contract sales people it used to exclusively hawk the Transcept Pharmaceuticals Inc.-developed middle-of-the-night sleep drug Intermezzo. Intermezzo will continue to be sold through Purdue's roughly 525-person analgesic sales force, Richmond-based Transcept (NASDAQ: TSPT) said Monday in a Securities and Exchange Commission filing. The 90 contract sales reps concentrate on psychiatrists and other specialty prescribers. "We're both clearly disappointed with where Intermezzo is today," Transcept COO Thomas Soloway told analysts last week.

Help employers find you! Check out all the jobs and post your resume.



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->